Targeted Quantification of the Glycated Peptides of Human Serum Albumin.

[1]  O. Fiehn,et al.  Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival , 2016, Clinical Proteomics.

[2]  N. Meshram,et al.  Targeted quantification of N-1-(carboxymethyl) valine and N-1-(carboxyethyl) valine peptides of β-hemoglobin for better diagnostics in diabetes , 2016, Clinical Proteomics.

[3]  V. Mohan,et al.  Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE* , 2015, Molecular & Cellular Proteomics.

[4]  Brendan MacLean,et al.  Building high-quality assay libraries for targeted analysis of SWATH MS data , 2015, Nature Protocols.

[5]  Yuri A. Mirokhin,et al.  Tandem Mass Spectral Libraries of Peptides in Digests of Individual Proteins: Human Serum Albumin (HSA) * , 2014, Molecular & Cellular Proteomics.

[6]  Hemangi S. Bhonsle,et al.  “Zoom-In”—A Targeted Database Search for Identification of Glycation Modifications Analyzed by Untargeted Tandem Mass Spectrometry , 2012 .

[7]  Sameer Singh,et al.  Albumin competitively inhibits glycation of less abundant proteins. , 2008, Protein and peptide letters.

[8]  Anne Dawnay,et al.  Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. , 2003, The Biochemical journal.

[9]  H. Sano,et al.  N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. , 1996, Biochemistry.

[10]  J. Baynes,et al.  N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. , 1995, Biochemistry.